Annals of Allergy Asthma & Immunology最新文献

{"title":"Information for Readers","authors":"","doi":"10.1016/S1081-1206(24)01664-8","DOIUrl":"10.1016/S1081-1206(24)01664-8","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Page A1"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143178182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Symptomatology and management of peanut anaphylaxis","authors":"Roy Khalaf , Connor Prosty MD, BSc , Christine McCusker MD , Adam Bretholz MD , Mohammed Kaouache PhD , Ann E. Clarke MD, MSc , Judy Morris MD , Jocelyn Gravel MD, MSc , Rodrick Lim MD , Edmond S. Chan MD , Ran D. Goldman MD , Andrew O’ Keefe MD , Jennifer Gerdts BComm , Derek K. Chu MD, PhD , Julia Upton MD, MPH , Elana Hochstadter MD , Jocelyn Moisan MD, MSc , Xun Zhang PhD , Jennifer L.P. Protudjer PhD , Elissa M. Abrams MD, MPH , Moshe Ben-Shoshan MD, MSc","doi":"10.1016/j.anai.2024.09.014","DOIUrl":"10.1016/j.anai.2024.09.014","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 99-102"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reviewer Acknowledgement","authors":"","doi":"10.1016/S1081-1206(24)01705-8","DOIUrl":"10.1016/S1081-1206(24)01705-8","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages A8-A9"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of plastics in allergy, immunology, and human health","authors":"Leonardo Trasande MD, MPP","doi":"10.1016/j.anai.2024.06.029","DOIUrl":"10.1016/j.anai.2024.06.029","url":null,"abstract":"<div><div><span><span>The effects of plastics on human health include allergy, </span>atopy<span><span>, asthma, and immune disruption, but the consequences of chemicals used in plastic materials span nearly every organ system and age group as well. Behavioral interventions to reduce plastic chemical exposures have reduced exposure in low- and high-income populations, yet health care providers know little about plastic chemical effects and seldom offer steps to patients to limit exposure. </span>Health care facilities<span> also use many products that increase the risk of chemical exposures, particularly for at-risk populations such as children in neonatal intensive care units. Given that disparities in plastic chemical exposure are well documented, collaborative efforts are needed between scientists and health care organizations, to develop products that improve provider knowledge about chemicals used in plastic materials and support the use of safer alternatives in </span></span></span>medical devices and other equipment.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 46-52"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Think again about cyclosporine for chronic spontaneous urticaria","authors":"Miles Weinberger MD","doi":"10.1016/j.anai.2024.10.021","DOIUrl":"10.1016/j.anai.2024.10.021","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Page 104"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding the needs of children and young people with food hypersensitivities","authors":"Holly Tallentire PsychD ,&nbsp;Heather Maddison-Roberts PsychD ,&nbsp;Rose-Marie Satherley PhD ,&nbsp;Lucy S. Hale PsychD ,&nbsp;Christina J. Jones PhD","doi":"10.1016/j.anai.2024.09.013","DOIUrl":"10.1016/j.anai.2024.09.013","url":null,"abstract":"<div><h3>Background</h3><div>Research has highlighted the psychosocial impact of living with food hypersensitivities (FHS) on children and young people (CYP). However, there is a paucity of qualitative data from CYP themselves in terms of the support they would like to receive to improve their psychological well-being.</div></div><div><h3>Objective</h3><div>To further understand firsthand the experiences of CYP with FHS including the challenges they face and to inform structural changes in how their psychological well-being is supported.</div></div><div><h3>Methods</h3><div>CYP aged 8 to 17 years were recruited with self-reported food allergy or celiac disease and asked about their experiences of living with and the psychological impact of FHS, through online, semistructured interviews. Interviews were transcribed verbatim, and data were analyzed using reflexive thematic analysis.</div></div><div><h3>Results</h3><div>A total of 25 CYP participated in the interviews. Three themes were generated, which addressed an aspect of change that CYP felt would enable support and improve their well-being: desire to feel heard, need for control, and appreciation of the severity of their FHS.</div></div><div><h3>Conclusion</h3><div>This is the first study to investigate what CYP with FHS would find beneficial for their psychological well-being with recommendations provided as to how these may be implemented across various systems. Recommendations include health professionals being more aware of the psychosocial impact from diagnosis, schools being more open and consistent with FHS management strategies, and friends being educated on the management of FHS.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 79-84"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guidance for the evaluation by payors of claims submitted using Current Procedural Terminology codes 95165, 95115, and 95117","authors":"J. Allen Meadows MD ,&nbsp;Gary N. Gross MD ,&nbsp;Anita N. Wasan MD ,&nbsp;Dole P. Baker MD ,&nbsp;Amber Patterson MD ,&nbsp;Robert Puchalski MD ,&nbsp;Anil Nanda MD ,&nbsp;Jami Lucas BS ,&nbsp;J. Wesley Sublett MD, MPH ,&nbsp;Paul V. Williams MD","doi":"10.1016/j.anai.2024.09.011","DOIUrl":"10.1016/j.anai.2024.09.011","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 107-109"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Care of asthma—a rapidly moving story","authors":"John Oppenheimer MD ,&nbsp;Thomas Casale MD","doi":"10.1016/j.anai.2024.10.022","DOIUrl":"10.1016/j.anai.2024.10.022","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 1-2"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is it time to talk about remission in chronic rhinosinusitis?","authors":"Edsel M. Abud MD, PhD,&nbsp;Andrew A. White MD","doi":"10.1016/j.anai.2024.10.014","DOIUrl":"10.1016/j.anai.2024.10.014","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 5-6"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of intravenous immunoglobulin treatment of immunocompromised patients with viral respiratory infections","authors":"Eric Moughames MD ,&nbsp;Sevag Sakayan MD ,&nbsp;Laura Prichett PhD ,&nbsp;Michael Chris Runken PharmD ,&nbsp;Dawn Borst RN ,&nbsp;Jody Tversky MD ,&nbsp;Antoine Azar MD","doi":"10.1016/j.anai.2024.09.001","DOIUrl":"10.1016/j.anai.2024.09.001","url":null,"abstract":"<div><h3>Background</h3><div>Limited guidelines exist for treating immunocompromised patients hospitalized for acute viral respiratory infection. Little is known about clinical and economic benefits of intravenous immunoglobulin (IVIG) administration in patients with acute viral respiratory infections.</div></div><div><h3>Objective</h3><div>To compare clinical and economic outcomes among immunocompromised patients hospitalized with viral respiratory infections who received IVIG with those who did not.</div></div><div><h3>Methods</h3><div>We performed a retrospective cohort study on all patients hospitalized for a respiratory viral infection between 2011 and 2016 at 2 large academic centers including data on age, sex, virus species, immunosuppression type, and receipt of IVIG. Outcomes included death, hospital readmission, length of stay (LOS) in the hospital, and LOS in the intensive care unit (ICU).</div></div><div><h3>Results</h3><div>A total of 270 patient admissions were reviewed, and 35.6% received IVIG. The average age was 40.6 years, 50% were female, and 74% were transplant patients. The most common virus was rhinovirus (50.7%). Use of IVIG was significantly associated with a shorter ICU LOS (β = −0.534, <em>P</em> = .012) and a longer hospital LOS (β = 0.887, <em>P</em> &lt; .01). IVIG administered within 48 hours of hospitalization (n = 229) was associated with a shorter ICU LOS (β = −2.08, <em>P</em> = .001) and a shorter hospital LOS for patients hospitalized at least 2 days (β = −0.461, <em>P</em> = .007). There were no significant differences in readmission rates or death.</div></div><div><h3>Conclusion</h3><div>This double-center, retrospective cohort analysis is one of the first studies to evaluate the effect of IVIG on immunocompromised patients hospitalized with respiratory viral infections. IVIG was associated with a shorter hospital and ICU LOS, especially when administered within 48 hours of admission.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"134 1","pages":"Pages 85-90.e1"},"PeriodicalIF":5.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142209620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}